Identification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles
Authors
Mathew, AnujaTerajima, Masanori
West, Kim
Green, Sharone
Rothman, Alan L.
Ennis, Francis A.
Kennedy, Jeffrey S.
UMass Chan Affiliations
Center for Infectious Disease and Vaccine ResearchDocument Type
Journal ArticlePublication Date
2005-02-09Keywords
Amino Acid Sequence; Animals; Cell Degranulation; Cell Line, Tumor; Cells, Cultured; *Cytotoxicity Tests, Immunologic; Epitopes, T-Lymphocyte; H-2 Antigens; Injections, Intraperitoneal; Interferon Type II; Kinetics; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Peptide Fragments; T-Lymphocytes, Cytotoxic; Vaccinia virus; Viral VaccinesLife Sciences
Medicine and Health Sciences
Metadata
Show full item recordAbstract
Murine T cell epitopes against vaccinia virus (VV) have not been characterized to date in part due to the large and complex genome of VV. We have identified and characterized two CD8+ T cell epitopes on the A47L (modified VV Ankara strain (MVA)-029) and J6R (MVA-043) proteins of VV that are Db and Kb restricted, respectively. Following i.p. immunization with VV New York City Board of Health (NYCBH) strain, MVA-029 peptide-stimulated splenocytes secreted IFN-gamma from 7 days to 7 mo postimmunization, and virus-stimulated effectors were also able to lyse MVA-029-pulsed target cells at the same time points. In contrast, MVA-043 peptide-stimulated splenocytes secreted very low levels of IFN-gamma only at day 7 but maintained the ability to lyse target cells up to 2 mo postimmunization. Both MVA-029 and MVA-043 peptide-stimulated lymph node cells degranulated similarly as assessed by Ag-induced CD107 expression. T cell responses to whole-virus stimulation remained robust and steady during the acute and memory T cell response to VV. Identification of T cell epitopes on VV will enable further studies to increase our understanding of the role of CD8+ T cells in VV infection and assist in the design of new protective strategies.Source
J Immunol. 2005 Feb 15;174(4):2212-9.
DOI
10.4049/jimmunol.174.4.2212Permanent Link to this Item
http://hdl.handle.net/20.500.14038/34159PubMed ID
15699154Related Resources
ae974a485f413a2113503eed53cd6c53
10.4049/jimmunol.174.4.2212